AD

4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine(CAS: 898280-07-4)

4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine
CAS Number

Related Products

Other Suppliers for 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine

Basic Information

Molecular Formula
C22H31N9O
Molecular Weight
437.55 g/mol

Chemical Identifiers

SMILES
CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)N3CCN(CC3)C)NC4=NNC(=C4)C5CC5
InChIKey
ALKJNCZNEOTEMP-UHFFFAOYSA-N

Database References

MDL Number
MFCD26793867

FAQ

The compound 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine (CAS: 898280-07-4) falls under the regulation of the Chemicals of Very High Concern (SVHC) under the REACH regulations. It may also require classification and labeling according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), which includes health, environmental, and physical hazards. In the U.S., the compound may be regulated by the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) based on its intended use.
When synthesizing 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine (CAS: 898280-07-4), alternative reagents such as other pyrimidine derivatives or diamines with similar functional groups may be considered. It is important to evaluate the availability, cost, and reactivity of these alternatives in relation to the desired product. Analogous compounds with similar structures might also serve as viable alternatives.
The research trend for 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine (CAS: 898280-07-4) is primarily focused on its application in pharmaceuticals, particularly in the development of new drugs for treating diseases such as cancer and inflammation. The compound is also being explored for its potential as a therapeutic agent due to its specific interactions with biological targets. Market trends indicate increasing interest in this compound, driven by its unique pharmacological properties.
Waste containing 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine (CAS: 898280-07-4) should be collected in appropriate, leak-proof containers and stored in a secure location. Treatment and disposal of this waste should follow the guidelines of the local environmental protection agency. Incineration is a common method for waste disposal, but professional waste disposal services may also be necessary. Ensure that all handling and disposal methods comply with the regulations of the REACH and GHS to minimize environmental impact.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

info@atomaxchem.com

Mobile

13417589054